Rediscovering plant-based drugs.
作者信息
Littleton John, Falcone Deane, Davies H Maelor
出版信息
Nat Biotechnol. 2003 Aug;21(8):843-4. doi: 10.1038/nbt0803-843b.
PMID:12894188
Abstract
摘要
相似文献
1
Rediscovering plant-based drugs.
Nat Biotechnol. 2003 Aug;21(8):843-4. doi: 10.1038/nbt0803-843b.
2
Prescription for an ailing pharmaceutical industry.
Nat Biotechnol. 2002 Apr;20(4):331. doi: 10.1038/nbt0402-331.
3
Biotechnology partnerships--medicine for an ailing industry?
Nat Biotechnol. 2003 Aug;21(8):847-8. doi: 10.1038/nbt0803-847.
4
Merck moves into biotech.
Nat Biotechnol. 2006 Jul;24(7):730. doi: 10.1038/nbt0706-730.
5
Deal watch: Trends in platform technology deal-making.
Nat Rev Drug Discov. 2009 Dec;8(12):923. doi: 10.1038/nrd3065.
6
The power of genomics to transform the biotechnology industry.
Nat Biotechnol. 1998 May;16 Suppl:25-7. doi: 10.1038/5408.
7
The 802 million dollars fallacy.
Nat Biotechnol. 2004 Sep;22(9):1076. doi: 10.1038/nbt0904-1076a.
8
Financial Times Global Pharmaceutical & Biotechnology Conference 2009.
IDrugs. 2010 Jan;13(1):26-9.
9
SOZO--a Euro-Japanese biotechnology conference.
IDrugs. 2005 Jul;8(7):560-2.
10
Private company profiles.
Nat Biotechnol. 2003 Jul;21 Suppl:BE23-8.
Zotero 插件